Neumora Therapeutics
NMRA
NMRA
98 hedge funds and large institutions have $41.2M invested in Neumora Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
15% less funds holding
Funds holding: 115 → 98 (-17)
37% less capital invested
Capital invested by funds: $65.2M → $41.2M (-$24.1M)
40% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 40
Holders
98
Holding in Top 10
1
Calls
$143K
Puts
$54K
Top Buyers
| 1 | +$772K | |
| 2 | +$526K | |
| 3 | +$473K | |
| 4 |
Millennium Management
New York
|
+$376K |
| 5 |
AC
AlphaCore Capital
La Jolla,
California
|
+$248K |
Top Sellers
| 1 | -$2.55M | |
| 2 | -$1.8M | |
| 3 | -$1.01M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$777K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$585K |
